Clinical trial
Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in…
NCT00456235 · University Hospital, Limoges, Other · Completed
Key facts
| NCT number | NCT00456235 |
|---|---|
| Title | Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors |
| Official title | Interruption of the Calcineurine Inhibitors (ICN) and Introduction of Mycophenolate Mofetil (MMF) in Liver Transplant Patients With Side Effects Due to ICN: Study of the Reduction of the Risks of Rejection by Mycophenolate Mofetil Therapeutic Drug Monitoring |
| Acronym | MONOCEPT |
| Lead sponsor | University Hospital, Limoges, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplantation |
| Intervention type | Drug |
| Interventions | Mycophénolate Mofétil, Ciclosporine A, Tacrolimus |
| Enrollment | 92 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2011 |
| First posted | Apr 4, 2007 |
| Last update posted | Apr 17, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: